Latest Parkman Healthcare Partners LLC Stock Portfolio
$746Million– No. of Holdings #89
Parkman Healthcare Partners LLC Performance:
2024 Q2: -1%YTD: 7.48%2023: 6.09%
Performance for 2024 Q2 is -1%, and YTD is 7.48%, and 2023 is 6.09%.
About Parkman Healthcare Partners LLC and 13F Hedge Fund Stock Holdings
Parkman Healthcare Partners LLC is a hedge fund based in STAMFORD, CT. On 27-Mar-2023, the fund reported that it had an AUM (Regulated Assets under Management) of $591.9 Millions. In it's latest 13F Holdings report, Parkman Healthcare Partners LLC reported an equity portfolio of $746.6 Millions as of 30 Jun, 2024.
The top stock holdings of Parkman Healthcare Partners LLC are BSX, PODD, UTHR. The fund has invested 5.7% of it's portfolio in BOSTON SCIENTIFIC CORP and 4.8% of portfolio in INSULET CORP.
The fund managers got completely rid off INSPIRE MED SYS INC (INSP), SILK RD MED INC (SILK) and KINIKSA PHARMACEUTICALS LTD (KNSA) stocks. They significantly reduced their stock positions in FORTREA HLDGS INC, CENCORA INC (ABC) and AKOYA BIOSCIENCES INC (AKYA). Parkman Healthcare Partners LLC opened new stock positions in AGIOS PHARMACEUTICALS INC (AGIO), KINIKSA PHARMACEUTICALS INTL and HUMANA INC (HUM). The fund showed a lot of confidence in some stocks as they added substantially to THIRD HARMONIC BIO INC (THRD), INTRA-CELLULAR THERAPIES INC (ITCI) and ALPHATEC HLDGS INC (ATEC).
The top stock holdings of Parkman Healthcare Partners LLC are BSX, PODD, UTHR. The fund has invested 5.7% of it's portfolio in BOSTON SCIENTIFIC CORP and 4.8% of portfolio in INSULET CORP.
The fund managers got completely rid off INSPIRE MED SYS INC (INSP), SILK RD MED INC (SILK) and KINIKSA PHARMACEUTICALS LTD (KNSA) stocks. They significantly reduced their stock positions in FORTREA HLDGS INC, CENCORA INC (ABC) and AKOYA BIOSCIENCES INC (AKYA). Parkman Healthcare Partners LLC opened new stock positions in AGIOS PHARMACEUTICALS INC (AGIO), KINIKSA PHARMACEUTICALS INTL and HUMANA INC (HUM). The fund showed a lot of confidence in some stocks as they added substantially to THIRD HARMONIC BIO INC (THRD), INTRA-CELLULAR THERAPIES INC (ITCI) and ALPHATEC HLDGS INC (ATEC).
Parkman Healthcare Partners LLC Equity Portfolio Value
Last Reported on: 14 Aug, 2024
Parkman Healthcare Partners LLC Annual Return Estimates Vs S&P 500
Our best estimate is that Parkman Healthcare Partners LLC made a return of -1% in the last quarter. In trailing 12 months, it's portfolio return was 12.44%.
New Buys
| Ticker | $ Bought |
|---|---|
| agios pharmaceuticals inc | 19,249,500 |
| kiniksa pharmaceuticals intl | 12,082,100 |
| icon plc | 11,615,900 |
| humana inc | 11,223,300 |
| gilead sciences inc | 8,576,250 |
| bristol-myers squibb co | 8,306,000 |
| anaptysbio inc | 6,423,050 |
| avadel pharmaceuticals plc | 5,318,740 |
New stocks bought by Parkman Healthcare Partners LLC
Additions
| Ticker | % Inc. |
|---|---|
| third harmonic bio inc | 233 |
| intra-cellular therapies inc | 164 |
| alphatec hldgs inc | 153 |
| avid bioservices inc | 129 |
| amicus therapeutics inc | 121 |
| insulet corp | 97.15 |
| nurix therapeutics inc | 89.87 |
| elevance health inc | 83.01 |
Additions to existing portfolio by Parkman Healthcare Partners LLC
Reductions
| Ticker | % Reduced |
|---|---|
| fortrea hldgs inc | -64.29 |
| cencora inc | -61.17 |
| akoya biosciences inc | -59.07 |
| vyne therapeutics inc | -50.43 |
| tenet healthcare corp | -47.53 |
| augmedix inc | -46.83 |
| merus n v | -43.65 |
| livanova plc | -41.27 |
Parkman Healthcare Partners LLC reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| standard biotools inc | -4,526,790 |
| silk rd med inc | -15,551,800 |
| oscar health inc | -12,361,200 |
| butterfly network inc | -810,000 |
| deciphera pharmaceuticals in | -11,470,800 |
| kiniksa pharmaceuticals ltd | -12,748,800 |
| lyra therapeutics inc | -3,994,760 |
| acumen pharmaceuticals inc | -2,335,460 |
Parkman Healthcare Partners LLC got rid off the above stocks
Sector Distribution
Parkman Healthcare Partners LLC has about 91.7% of it's holdings in Healthcare sector.
| Sector | % |
|---|---|
| Healthcare | 91.7 |
| Others | 7.7 |
Market Cap. Distribution
Parkman Healthcare Partners LLC has about 42.8% of it's portfolio invested in the large-cap and mega-cap stocks.
| Category | % |
|---|---|
| LARGE-CAP | 38.9 |
| SMALL-CAP | 29.4 |
| MID-CAP | 17.5 |
| UNALLOCATED | 6.9 |
| MEGA-CAP | 3.9 |
| MICRO-CAP | 3.1 |
Stocks belong to which Index?
About 73.2% of the stocks held by Parkman Healthcare Partners LLC either belong to S&P 500 or RUSSELL 2000 index.
| Index | % |
|---|---|
| RUSSELL 2000 | 42.7 |
| S&P 500 | 30.5 |
| Others | 26.9 |
Parkman Healthcare Partners LLC Holdings Map
This heatmap illustrates the top 50 positions within the fund's portfolio.
Current Stock Holdings of Parkman Healthcare Partners LLC
Parkman Healthcare Partners LLC has 89 stocks in it's portfolio. About 35.3% of the portfolio is in top 10 stocks. SDGR proved to be the most loss making stock for the portfolio. UTHR was the most profitable stock for Parkman Healthcare Partners LLC last quarter.
Last Reported on: 14 Aug, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options | |
|---|---|---|---|---|---|---|---|---|
| ABC | cencora inc | 1.15 | 38,014 | 8,564,550 | reduced | -61.17 | ||
| ABOS | acumen pharmaceuticals inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| ABT | abbott labs | 1.70 | 121,913 | 12,668,000 | added | 0.18 | ||
| ACLX | arcellx inc | 1.16 | 156,843 | 8,656,160 | added | 0.16 | ||
| AGIO | agios pharmaceuticals inc | 2.58 | 446,416 | 19,249,500 | new | |||
| AKYA | akoya biosciences inc | 0.12 | 375,536 | 878,754 | reduced | -59.07 | ||
| ANAB | anaptysbio inc | 0.86 | 256,307 | 6,423,050 | new | |||
| ANNX | annexon inc | 0.22 | 326,845 | 1,601,540 | reduced | -5.72 | ||
| APLT | applied therapeutics inc | 0.72 | 1,148,310 | 5,362,590 | reduced | -38.09 | ||
| ARDX | ardelyx inc | 0.15 | 150,192 | 1,112,920 | reduced | -24.9 | ||
| ARVN | arvinas inc | 0.45 | 125,161 | 3,331,790 | added | 0.15 | ||
| ATEC | alphatec hldgs inc | 1.19 | 852,416 | 8,907,750 | added | 153 | ||
| AUGX | augmedix inc | 0.07 | 566,845 | 498,824 | reduced | -46.83 | ||
| AVDL | avadel pharmaceuticals plc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BCRX | biocryst pharmaceuticals inc | 0.33 | 400,448 | 2,474,770 | new | |||
| BCYC | bicycle therapeutics plc | 1.45 | 535,063 | 10,829,700 | added | 2.06 | ||
| BDX | becton dickinson & co | 2.13 | 68,167 | 15,931,300 | added | 49.5 | ||
| BFLY | butterfly network inc | 0.00 | 0.00 | 0.00 | sold off | -100 | ||
| BMY | bristol-myers squibb co | 1.11 | 200,000 | 8,306,000 | new | |||
| BSX | boston scientific corp | 5.69 | 551,592 | 42,478,100 | added | 29.64 | ||